S. Telang
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
-
- Metabolism, Diabetes, and Cancer
- Mitochondrial Function and Pathology
- Epigenetics and DNA Methylation
- RNA modifications and cancer
Papers in
- Oncology 8
- Cancer-related Molecular Pathways 4
- CAR-T cell therapy research 3
-
- Cancer, Hypoxia, and Metabolism 7
- Co-authors
- Jason Chesney (10 shared papers)Amy Clem (5 shared papers)Abdullah Yalçın (3 shared papers)Brian F. Clem (4 shared papers)John W. Eaton (2 shared papers)Andrew N. Lane (2 shared papers)Alden C. Klarer (3 shared papers)Julie O’Neal (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Oncogene (2 papers)QJM (1 paper)Cell Death and Disease (1 paper)Current Pharmaceutical Biotechnology (1 paper)
- Partner nations
- United StatesIndiaTürkiye
In The Last Decade
S. Telang
13 papers receiving 459 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 254
- Molecular Biology 337
- Oncology 98
- Cell Biology 42
- Nutrition and Dietetics 25
Countries citing papers authored by S. Telang
This map shows the geographic impact of S. Telang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Telang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Telang more than expected).
Fields of papers citing papers by S. Telang
This network shows the impact of papers produced by S. Telang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Telang. The network helps show where S. Telang may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Telang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 155 | |
| 2 | 2006 | 136 | |
| 3 | 2009 | 82 | |
| 4 | 2015 | 26 | |
| 5 | 2015 | 24 | |
| 6 | 2013 | 19 | |
| 7 | 2009 | 13 | |
| 8 | 2011 | 4 | |
| 9 | 2008 | 2 | |
| 10 | 2006 | 1 | |
| 11 | 2009 | 1 | |
| 12 | 2014 | 1 | |
| 13 | 2023 | 1 | |
| 14 | 2019 | 0 |
About S. Telang
S. Telang is a scholar working on Oncology, Cancer Research, Molecular Biology, Cell Biology and Immunology, having authored 14 papers that have together received 465 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (7 papers), Cancer-related Molecular Pathways (4 papers), Metabolism, Diabetes, and Cancer (3 papers), Immunotherapy and Immune Responses (3 papers), CAR-T cell therapy research (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Microtubule and mitosis dynamics (2 papers) and Lipid metabolism and disorders (1 paper). The work is most often cited by research in Cancer Research (254 citations), Molecular Biology (337 citations), Oncology (98 citations), Cell Biology (42 citations) and Nutrition and Dietetics (25 citations). S. Telang has collaborated with scholars based in United States, India and Türkiye. Frequent co-authors include Jason Chesney, Amy Clem, Abdullah Yalçın, Brian F. Clem, John W. Eaton, Andrew N. Lane, Alden C. Klarer, Julie O’Neal, Richard Bucala and Yoannis Imbert-Fernandez. Their work appears in journals such as Journal of Clinical Oncology, Oncogene, QJM, Cell Death and Disease and Current Pharmaceutical Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.